Chang Liu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biological Psychiatry top 10%
Papers in
-
- RNA modifications and cancer 12
- RNA Interference and Gene Delivery 9
- Circular RNAs in diseases 7
- Advanced biosensing and bioanalysis techniques 7
- Epidemiology 24
- Co-authors
- Changmin Hu (1 shared paper)Mingpu Qi (1 shared paper)Yingyu Chen (1 shared paper)Aizhen Guo (1 shared paper)Yuhui Liu (1 shared paper)Xiaohong Kong (19 shared papers)Ruining Liu (1 shared paper)Xifang Zhu (1 shared paper)
- Journals
- Frontiers in Microbiology (2 papers)Frontiers in Cellular and Infection Microbiology (2 papers)Biochemical and Biophysical Research Communications (2 papers)Science China Materials (2 papers)Pathogens (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chang Liu
151 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 469
- Biological Psychiatry 58
- Molecular Biology 1.3k
- Virology 82
- Immunology 321
Countries citing papers authored by Chang Liu
This map shows the geographic impact of Chang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Liu more than expected).
Fields of papers citing papers by Chang Liu
This network shows the impact of papers produced by Chang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Liu. The network helps show where Chang Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways Hit paper breakdown → | 2016 | 393 |
| 2 | 2018 | 248 | |
| 3 | 2006 | 105 | |
| 4 | 2004 | 88 | |
| 5 | 2020 | 76 | |
| 6 | 2012 | 76 | |
| 7 | 2016 | 55 | |
| 8 | 2020 | 52 | |
| 9 | 2016 | 51 | |
| 10 | 2010 | 47 | |
| 11 | 2013 | 39 | |
| 12 | 2010 | 38 | |
| 13 | 2019 | 36 | |
| 14 | 2017 | 36 | |
| 15 | 2016 | 33 | |
| 16 | 2016 | 33 | |
| 17 | 2021 | 32 | |
| 18 | 2020 | 32 | |
| 19 | 2017 | 31 | |
| 20 | 2014 | 31 |
About Chang Liu
Chang Liu is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Immunology and Virology, having authored 160 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers), RNA Interference and Gene Delivery (9 papers), HIV/AIDS drug development and treatment (8 papers), Circular RNAs in diseases (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). The work is most often cited by research in Cancer Research (469 citations), Biological Psychiatry (58 citations), Molecular Biology (1.3k citations), Virology (82 citations) and Immunology (321 citations). Chang Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Changmin Hu, Mingpu Qi, Yingyu Chen, Aizhen Guo, Yuhui Liu, Xiaohong Kong, Ruining Liu, Xifang Zhu, Tingming Liang and Jack T. Marchewka. Their work appears in journals such as Frontiers in Microbiology, Frontiers in Cellular and Infection Microbiology, Biochemical and Biophysical Research Communications, Science China Materials and Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.